Table 2.
Regression coefficient (β) | SE | P | OR | 95% CI for OR (lower-upper) | |
---|---|---|---|---|---|
Step 1 | |||||
Age | −0.006 | 0.023 | 0.81 | 0.994 | 0.950-1.041 |
Hospitalization period | −0.005 | 0.259 | 0.98 | 0.995 | 0.599-1.651 |
Hydroxychloroquine (1) | 5.138 | 2.944 | 0.08 | 170.3 | 0.531-5.46E+04 |
Ribavirin (1) | −1.854 | 4.555 | 0.68 | 0.157 | 0.000-1180.949 |
Lopinavir/ritonavir (1) | 0.858 | 1.829 | 0.64 | 2.359 | 0.065-85.041 |
Intravenous antibiotics (1) | −1.212 | 3.085 | 0.69 | 0.298 | 0.001-125.876 |
Hydroxychloroquine (1) by age by severity (1) | 0.332 | 758.358 | 1.00 | 1.394 | 0.000-NA |
Lopinavir/ritonavir (1) by age by severity (1) | −0.639 | 766.387 | 1.00 | 0.528 | 0.000-NA |
Ribavirin (1) by age by severity (1) | 0.236 | 110.643 | 1.00 | 1.266 | 0.000-1.91E+94 |
Diabetes (1) | −2.310 | 1.750 | 0.19 | 0.099 | 0.003-3.063 |
Hypertension (1) | 2.513 | 2.062 | 0.22 | 12.338 | 0.217-702.334 |
Chronic obstructive pulmonary disease/asthma (1) | 34.177 | 10895.718 | 1.00 | 6.96E+14 | 0.000-NA |
Azithromycin (1) by hydroxychloroquine (1) | −0.087 | 11.366 | 0.99 | 0.917 | 0.000-4.34E+09 |
Age by azithromycin (1) by hydroxychloroquine (1) | 0.028 | 0.207 | 0.89 | 1.028 | 0.685-1.544 |
Step 13 | |||||
Hydroxychloroquine (1) | 4.125 | 0.983 | <0.001 | 61.859 | 9.009-424.722 |
Lopinavir/ritonavir (1) by age by severity (1) | −0.081 | 0.020 | <0.001 | 0.922 | 0.887-0.958 |
Complete 13 steps of logistic regression is provided in the electronic Supplementary Material [Supplementary Table 2]. OR=Odds ratio; CI=Confidence interval; SE=Standard deviation; NA=Not applicable